Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
about
Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatmentThe role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicityA Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats.Spironolactone and colitis: increased mortality in rodents and in humans.Effects of vitamin D on kidney histology and trpv1 channels in doxorubicin-induced nephropathyProtective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro.TXNIP/TRX/NF-κB and MAPK/NF-κB pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats.Grape-Derived Polyphenols Prevent Doxorubicin-Induced Blunted EDH-Mediated Relaxations in the Rat Mesenteric Artery: Role of ROS and Angiotensin IIRegulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure.Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature.Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue.Acute adriamycin-induced cardiotoxicity is exacerbated by angiotension IIProtective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats.Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and ApoptosisTelmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats.Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats.Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy.Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis.Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury.Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats.Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1 R upregulation are required for doxorubicin-induced cardiotoxicity.Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity.Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammation and apoptosis.Micro RNA-320 as a novel potential biomarker in renal ischemia reperfusion.Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.Cardioprotection mechanism of mangiferin on doxorubicin-induced rats: Focus on intracellular calcium regulation.Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren.Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice
P2860
Q33648557-1BE3B0EE-9A35-4755-9211-1BCE76D5B7CCQ35024342-DEA59CE0-6892-4065-8297-2EAC23726FDCQ35368603-A0A607E7-E8D2-4094-9EFB-183432F83C30Q35553674-A06E3457-13A2-4888-9690-FABA03782EAAQ35785467-DC0F9544-576B-4E74-9902-A92A7B18ED23Q35835824-858AC95C-E650-40D8-8B7F-8BEAA0B80CC3Q36367199-64373E19-128F-48A8-A853-8708D4C00ECCQ36670728-F026673A-B47D-408D-B035-D29A8B262388Q37166687-9711204D-3764-444A-965F-20AA40C476BDQ37728773-87D053ED-AFBC-46AF-B428-375DA352F384Q38105163-231FBA22-BC24-41F1-9CE1-2568B86DAA1DQ38638629-3AF59D07-C78B-4A71-9EED-C7C499C149AAQ40736861-DD033212-5069-49C9-BFA9-F3BE5A698CE4Q41376836-C1B4F95A-AD31-4553-987F-8775708AEDAFQ41901068-40C1402D-7ED2-4D8A-993E-8DD24D6A2AA6Q42429995-C472DC52-403E-4CAD-AC47-C682F1F60B63Q42542336-55446D9F-A98A-4F34-AC2F-97BC00F17DC1Q42747102-B6EE3761-FD5B-4C8D-8A87-4C3C226F0D1DQ42835421-3ACA589A-D4DA-4638-96FC-CA2F876C5A16Q42918152-C313C2A1-8CED-4333-8C4A-718DE0F24006Q43199588-D72FF291-B63F-4476-8C81-FD700C0D99CCQ43889083-F4564A07-583C-480B-ABE1-59A169B5C613Q44202978-B9F36008-AFE3-425C-AA41-43B831A042AEQ46319113-93C3861C-580D-4BD6-B72C-BFE6F1DFE47EQ46403967-B942C458-F3CE-46A0-AF3F-BBA87F92CBB2Q46930825-52A1AFF9-CD7B-4EC6-B3F6-5F4F5EDB59C2Q46935336-75FA40ED-301F-4E7D-A19F-5A2FD64AD96CQ51717087-05D9798F-72C4-468E-867D-A86487023622Q51734447-981B4850-624B-4075-818A-E748447B94FEQ53230021-2F180ADA-0A68-4497-B64D-6A766E4F3FFBQ53320516-25259D71-453F-4941-B5A9-BD0FA9FF7424Q53776493-DCE9E8F3-96C8-4258-A954-ACC95AAC4079Q54324332-99206852-F20E-42B0-A072-F53A4D08CD9BQ58366410-296192DB-5F06-4D82-B327-F0BB0636675B
P2860
Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Angiotensin-converting enzyme inhibition and angiotensin AT
@nl
Angiotensin-converting enzyme ...... iotoxicity and nephrotoxicity.
@en
type
label
Angiotensin-converting enzyme inhibition and angiotensin AT
@nl
Angiotensin-converting enzyme ...... iotoxicity and nephrotoxicity.
@en
prefLabel
Angiotensin-converting enzyme inhibition and angiotensin AT
@nl
Angiotensin-converting enzyme ...... iotoxicity and nephrotoxicity.
@en
P2093
P1476
Angiotensin-converting enzyme ...... iotoxicity and nephrotoxicity.
@en
P2093
Hussian I El-Bitar
Mohamed A Ibrahim
Osama M Ashour
Salama R Abdel-Rahim
Wafaey Gomaa
Yasmin F Ibrahim
P304
P356
10.1016/J.PHRS.2009.05.007
P577
2009-05-23T00:00:00Z